The Targeted DNA/RNA Sequencing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Targeted DNA/RNA Sequencing market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Human Biomedical Research accounting for % of the Targeted DNA/RNA Sequencing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While DNA-based Targeted Sequencing segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Targeted DNA/RNA Sequencing include Illumina, Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, GATC Biotech Ag, and Oxford Nanopore Technologies, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Targeted DNA/RNA Sequencing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
DNA-based Targeted Sequencing
RNA-based Targeted Sequencing
Market segment by Application, can be divided into
Human Biomedical Research
Plant & Animal Sciences
Drug Discovery
Others
Market segment by players, this report covers
Illumina, Inc.
F. Hoffmann-La Roche Ltd
Agilent Technologies
GATC Biotech Ag
Oxford Nanopore Technologies
Thermo Fisher Scientific, Inc.
DNASTAR Inc.
QIAGEN
BGI
Perkin Elmer, Inc.
Pacific Biosciences of California, Inc.
Bio-Rad Laboratories, Inc.
Integrated DNA Technologies, Inc.
RainDance Technologies, Inc.
PierianDx
Genomatix GmbH
Macrogen, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Targeted DNA/RNA Sequencing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Targeted DNA/RNA Sequencing, with revenue, gross margin and global market share of Targeted DNA/RNA Sequencing from 2019 to 2022.
Chapter 3, the Targeted DNA/RNA Sequencing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Targeted DNA/RNA Sequencing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Targeted DNA/RNA Sequencing research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of Targeted DNA/RNA Sequencing
1.2 Classification of Targeted DNA/RNA Sequencing by Type
1.2.1 Overview: Global Targeted DNA/RNA Sequencing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Targeted DNA/RNA Sequencing Revenue Market Share by Type in 2021
1.2.3 DNA-based Targeted Sequencing
1.2.4 RNA-based Targeted Sequencing
1.3 Global Targeted DNA/RNA Sequencing Market by Application
1.3.1 Overview: Global Targeted DNA/RNA Sequencing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Human Biomedical Research
1.3.3 Plant & Animal Sciences
1.3.4 Drug Discovery
1.3.5 Others
1.4 Global Targeted DNA/RNA Sequencing Market Size & Forecast
1.5 Global Targeted DNA/RNA Sequencing Market Size and Forecast by Region
1.5.1 Global Targeted DNA/RNA Sequencing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Targeted DNA/RNA Sequencing Market Size by Region, (2017-2022)
1.5.3 North America Targeted DNA/RNA Sequencing Market Size and Prospect (2017-2028)
1.5.4 Europe Targeted DNA/RNA Sequencing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Targeted DNA/RNA Sequencing Market Size and Prospect (2017-2028)
1.5.6 South America Targeted DNA/RNA Sequencing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Targeted DNA/RNA Sequencing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Targeted DNA/RNA Sequencing Market Drivers
1.6.2 Targeted DNA/RNA Sequencing Market Restraints
1.6.3 Targeted DNA/RNA Sequencing Trends Analysis
2 Company Profiles
2.1 Illumina, Inc.
2.1.1 Illumina, Inc. Details
2.1.2 Illumina, Inc. Major Business
2.1.3 Illumina, Inc. Targeted DNA/RNA Sequencing Product and Solutions
2.1.4 Illumina, Inc. Targeted DNA/RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Illumina, Inc. Recent Developments and Future Plans
2.2 F. Hoffmann-La Roche Ltd
2.2.1 F. Hoffmann-La Roche Ltd Details
2.2.2 F. Hoffmann-La Roche Ltd Major Business
2.2.3 F. Hoffmann-La Roche Ltd Targeted DNA/RNA Sequencing Product and Solutions
2.2.4 F. Hoffmann-La Roche Ltd Targeted DNA/RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
2.3 Agilent Technologies
2.3.1 Agilent Technologies Details
2.3.2 Agilent Technologies Major Business
2.3.3 Agilent Technologies Targeted DNA/RNA Sequencing Product and Solutions
2.3.4 Agilent Technologies Targeted DNA/RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Agilent Technologies Recent Developments and Future Plans
2.4 GATC Biotech Ag
2.4.1 GATC Biotech Ag Details
2.4.2 GATC Biotech Ag Major Business
2.4.3 GATC Biotech Ag Targeted DNA/RNA Sequencing Product and Solutions
2.4.4 GATC Biotech Ag Targeted DNA/RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 GATC Biotech Ag Recent Developments and Future Plans
2.5 Oxford Nanopore Technologies
2.5.1 Oxford Nanopore Technologies Details
2.5.2 Oxford Nanopore Technologies Major Business
2.5.3 Oxford Nanopore Technologies Targeted DNA/RNA Sequencing Product and Solutions
2.5.4 Oxford Nanopore Technologies Targeted DNA/RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Oxford Nanopore Technologies Recent Developments and Future Plans
2.6 Thermo Fisher Scientific, Inc.
2.6.1 Thermo Fisher Scientific, Inc. Details
2.6.2 Thermo Fisher Scientific, Inc. Major Business
2.6.3 Thermo Fisher Scientific, Inc. Targeted DNA/RNA Sequencing Product and Solutions
2.6.4 Thermo Fisher Scientific, Inc. Targeted DNA/RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
2.7 DNASTAR Inc.
2.7.1 DNASTAR Inc. Details
2.7.2 DNASTAR Inc. Major Business
2.7.3 DNASTAR Inc. Targeted DNA/RNA Sequencing Product and Solutions
2.7.4 DNASTAR Inc. Targeted DNA/RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 DNASTAR Inc. Recent Developments and Future Plans
2.8 QIAGEN
2.8.1 QIAGEN Details
2.8.2 QIAGEN Major Business
2.8.3 QIAGEN Targeted DNA/RNA Sequencing Product and Solutions
2.8.4 QIAGEN Targeted DNA/RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 QIAGEN Recent Developments and Future Plans
2.9 BGI
2.9.1 BGI Details
2.9.2 BGI Major Business
2.9.3 BGI Targeted DNA/RNA Sequencing Product and Solutions
2.9.4 BGI Targeted DNA/RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 BGI Recent Developments and Future Plans
2.10 Perkin Elmer, Inc.
2.10.1 Perkin Elmer, Inc. Details
2.10.2 Perkin Elmer, Inc. Major Business
2.10.3 Perkin Elmer, Inc. Targeted DNA/RNA Sequencing Product and Solutions
2.10.4 Perkin Elmer, Inc. Targeted DNA/RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Perkin Elmer, Inc. Recent Developments and Future Plans
2.11 Pacific Biosciences of California, Inc.
2.11.1 Pacific Biosciences of California, Inc. Details
2.11.2 Pacific Biosciences of California, Inc. Major Business
2.11.3 Pacific Biosciences of California, Inc. Targeted DNA/RNA Sequencing Product and Solutions
2.11.4 Pacific Biosciences of California, Inc. Targeted DNA/RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Pacific Biosciences of California, Inc. Recent Developments and Future Plans
2.12 Bio-Rad Laboratories, Inc.
2.12.1 Bio-Rad Laboratories, Inc. Details
2.12.2 Bio-Rad Laboratories, Inc. Major Business
2.12.3 Bio-Rad Laboratories, Inc. Targeted DNA/RNA Sequencing Product and Solutions
2.12.4 Bio-Rad Laboratories, Inc. Targeted DNA/RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
2.13 Integrated DNA Technologies, Inc.
2.13.1 Integrated DNA Technologies, Inc. Details
2.13.2 Integrated DNA Technologies, Inc. Major Business
2.13.3 Integrated DNA Technologies, Inc. Targeted DNA/RNA Sequencing Product and Solutions
2.13.4 Integrated DNA Technologies, Inc. Targeted DNA/RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Integrated DNA Technologies, Inc. Recent Developments and Future Plans
2.14 RainDance Technologies, Inc.
2.14.1 RainDance Technologies, Inc. Details
2.14.2 RainDance Technologies, Inc. Major Business
2.14.3 RainDance Technologies, Inc. Targeted DNA/RNA Sequencing Product and Solutions
2.14.4 RainDance Technologies, Inc. Targeted DNA/RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 RainDance Technologies, Inc. Recent Developments and Future Plans
2.15 PierianDx
2.15.1 PierianDx Details
2.15.2 PierianDx Major Business
2.15.3 PierianDx Targeted DNA/RNA Sequencing Product and Solutions
2.15.4 PierianDx Targeted DNA/RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 PierianDx Recent Developments and Future Plans
2.16 Genomatix GmbH
2.16.1 Genomatix GmbH Details
2.16.2 Genomatix GmbH Major Business
2.16.3 Genomatix GmbH Targeted DNA/RNA Sequencing Product and Solutions
2.16.4 Genomatix GmbH Targeted DNA/RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Genomatix GmbH Recent Developments and Future Plans
2.17 Macrogen, Inc.
2.17.1 Macrogen, Inc. Details
2.17.2 Macrogen, Inc. Major Business
2.17.3 Macrogen, Inc. Targeted DNA/RNA Sequencing Product and Solutions
2.17.4 Macrogen, Inc. Targeted DNA/RNA Sequencing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Macrogen, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Targeted DNA/RNA Sequencing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Targeted DNA/RNA Sequencing Players Market Share in 2021
3.2.2 Top 10 Targeted DNA/RNA Sequencing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Targeted DNA/RNA Sequencing Players Head Office, Products and Services Provided
3.4 Targeted DNA/RNA Sequencing Mergers & Acquisitions
3.5 Targeted DNA/RNA Sequencing New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Targeted DNA/RNA Sequencing Revenue and Market Share by Type (2017-2022)
4.2 Global Targeted DNA/RNA Sequencing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Targeted DNA/RNA Sequencing Revenue Market Share by Application (2017-2022)
5.2 Global Targeted DNA/RNA Sequencing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Targeted DNA/RNA Sequencing Revenue by Type (2017-2028)
6.2 North America Targeted DNA/RNA Sequencing Revenue by Application (2017-2028)
6.3 North America Targeted DNA/RNA Sequencing Market Size by Country
6.3.1 North America Targeted DNA/RNA Sequencing Revenue by Country (2017-2028)
6.3.2 United States Targeted DNA/RNA Sequencing Market Size and Forecast (2017-2028)
6.3.3 Canada Targeted DNA/RNA Sequencing Market Size and Forecast (2017-2028)
6.3.4 Mexico Targeted DNA/RNA Sequencing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Targeted DNA/RNA Sequencing Revenue by Type (2017-2028)
7.2 Europe Targeted DNA/RNA Sequencing Revenue by Application (2017-2028)
7.3 Europe Targeted DNA/RNA Sequencing Market Size by Country
7.3.1 Europe Targeted DNA/RNA Sequencing Revenue by Country (2017-2028)
7.3.2 Germany Targeted DNA/RNA Sequencing Market Size and Forecast (2017-2028)
7.3.3 France Targeted DNA/RNA Sequencing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Targeted DNA/RNA Sequencing Market Size and Forecast (2017-2028)
7.3.5 Russia Targeted DNA/RNA Sequencing Market Size and Forecast (2017-2028)
7.3.6 Italy Targeted DNA/RNA Sequencing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Targeted DNA/RNA Sequencing Revenue by Type (2017-2028)
8.2 Asia-Pacific Targeted DNA/RNA Sequencing Revenue by Application (2017-2028)
8.3 Asia-Pacific Targeted DNA/RNA Sequencing Market Size by Region
8.3.1 Asia-Pacific Targeted DNA/RNA Sequencing Revenue by Region (2017-2028)
8.3.2 China Targeted DNA/RNA Sequencing Market Size and Forecast (2017-2028)
8.3.3 Japan Targeted DNA/RNA Sequencing Market Size and Forecast (2017-2028)
8.3.4 South Korea Targeted DNA/RNA Sequencing Market Size and Forecast (2017-2028)
8.3.5 India Targeted DNA/RNA Sequencing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Targeted DNA/RNA Sequencing Market Size and Forecast (2017-2028)
8.3.7 Australia Targeted DNA/RNA Sequencing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Targeted DNA/RNA Sequencing Revenue by Type (2017-2028)
9.2 South America Targeted DNA/RNA Sequencing Revenue by Application (2017-2028)
9.3 South America Targeted DNA/RNA Sequencing Market Size by Country
9.3.1 South America Targeted DNA/RNA Sequencing Revenue by Country (2017-2028)
9.3.2 Brazil Targeted DNA/RNA Sequencing Market Size and Forecast (2017-2028)
9.3.3 Argentina Targeted DNA/RNA Sequencing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Targeted DNA/RNA Sequencing Revenue by Type (2017-2028)
10.2 Middle East & Africa Targeted DNA/RNA Sequencing Revenue by Application (2017-2028)
10.3 Middle East & Africa Targeted DNA/RNA Sequencing Market Size by Country
10.3.1 Middle East & Africa Targeted DNA/RNA Sequencing Revenue by Country (2017-2028)
10.3.2 Turkey Targeted DNA/RNA Sequencing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Targeted DNA/RNA Sequencing Market Size and Forecast (2017-2028)
10.3.4 UAE Targeted DNA/RNA Sequencing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Targeted DNA/RNA Sequencing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Targeted DNA/RNA Sequencing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Targeted DNA/RNA Sequencing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Targeted DNA/RNA Sequencing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Targeted DNA/RNA Sequencing Revenue Market Share by Region (2023-2028)
Table 6. Illumina, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. Illumina, Inc. Major Business
Table 8. Illumina, Inc. Targeted DNA/RNA Sequencing Product and Solutions
Table 9. Illumina, Inc. Targeted DNA/RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. F. Hoffmann-La Roche Ltd Corporate Information, Head Office, and Major Competitors
Table 11. F. Hoffmann-La Roche Ltd Major Business
Table 12. F. Hoffmann-La Roche Ltd Targeted DNA/RNA Sequencing Product and Solutions
Table 13. F. Hoffmann-La Roche Ltd Targeted DNA/RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 15. Agilent Technologies Major Business
Table 16. Agilent Technologies Targeted DNA/RNA Sequencing Product and Solutions
Table 17. Agilent Technologies Targeted DNA/RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. GATC Biotech Ag Corporate Information, Head Office, and Major Competitors
Table 19. GATC Biotech Ag Major Business
Table 20. GATC Biotech Ag Targeted DNA/RNA Sequencing Product and Solutions
Table 21. GATC Biotech Ag Targeted DNA/RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Oxford Nanopore Technologies Corporate Information, Head Office, and Major Competitors
Table 23. Oxford Nanopore Technologies Major Business
Table 24. Oxford Nanopore Technologies Targeted DNA/RNA Sequencing Product and Solutions
Table 25. Oxford Nanopore Technologies Targeted DNA/RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Thermo Fisher Scientific, Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Thermo Fisher Scientific, Inc. Major Business
Table 28. Thermo Fisher Scientific, Inc. Targeted DNA/RNA Sequencing Product and Solutions
Table 29. Thermo Fisher Scientific, Inc. Targeted DNA/RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. DNASTAR Inc. Corporate Information, Head Office, and Major Competitors
Table 31. DNASTAR Inc. Major Business
Table 32. DNASTAR Inc. Targeted DNA/RNA Sequencing Product and Solutions
Table 33. DNASTAR Inc. Targeted DNA/RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. QIAGEN Corporate Information, Head Office, and Major Competitors
Table 35. QIAGEN Major Business
Table 36. QIAGEN Targeted DNA/RNA Sequencing Product and Solutions
Table 37. QIAGEN Targeted DNA/RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. BGI Corporate Information, Head Office, and Major Competitors
Table 39. BGI Major Business
Table 40. BGI Targeted DNA/RNA Sequencing Product and Solutions
Table 41. BGI Targeted DNA/RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Perkin Elmer, Inc. Corporate Information, Head Office, and Major Competitors
Table 43. Perkin Elmer, Inc. Major Business
Table 44. Perkin Elmer, Inc. Targeted DNA/RNA Sequencing Product and Solutions
Table 45. Perkin Elmer, Inc. Targeted DNA/RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Pacific Biosciences of California, Inc. Corporate Information, Head Office, and Major Competitors
Table 47. Pacific Biosciences of California, Inc. Major Business
Table 48. Pacific Biosciences of California, Inc. Targeted DNA/RNA Sequencing Product and Solutions
Table 49. Pacific Biosciences of California, Inc. Targeted DNA/RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Bio-Rad Laboratories, Inc. Corporate Information, Head Office, and Major Competitors
Table 51. Bio-Rad Laboratories, Inc. Major Business
Table 52. Bio-Rad Laboratories, Inc. Targeted DNA/RNA Sequencing Product and Solutions
Table 53. Bio-Rad Laboratories, Inc. Targeted DNA/RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Integrated DNA Technologies, Inc. Corporate Information, Head Office, and Major Competitors
Table 55. Integrated DNA Technologies, Inc. Major Business
Table 56. Integrated DNA Technologies, Inc. Targeted DNA/RNA Sequencing Product and Solutions
Table 57. Integrated DNA Technologies, Inc. Targeted DNA/RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. RainDance Technologies, Inc. Corporate Information, Head Office, and Major Competitors
Table 59. RainDance Technologies, Inc. Major Business
Table 60. RainDance Technologies, Inc. Targeted DNA/RNA Sequencing Product and Solutions
Table 61. RainDance Technologies, Inc. Targeted DNA/RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. PierianDx Corporate Information, Head Office, and Major Competitors
Table 63. PierianDx Major Business
Table 64. PierianDx Targeted DNA/RNA Sequencing Product and Solutions
Table 65. PierianDx Targeted DNA/RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Genomatix GmbH Corporate Information, Head Office, and Major Competitors
Table 67. Genomatix GmbH Major Business
Table 68. Genomatix GmbH Targeted DNA/RNA Sequencing Product and Solutions
Table 69. Genomatix GmbH Targeted DNA/RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Macrogen, Inc. Corporate Information, Head Office, and Major Competitors
Table 71. Macrogen, Inc. Major Business
Table 72. Macrogen, Inc. Targeted DNA/RNA Sequencing Product and Solutions
Table 73. Macrogen, Inc. Targeted DNA/RNA Sequencing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Global Targeted DNA/RNA Sequencing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 75. Global Targeted DNA/RNA Sequencing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 76. Breakdown of Targeted DNA/RNA Sequencing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 77. Targeted DNA/RNA Sequencing Players Head Office, Products and Services Provided
Table 78. Targeted DNA/RNA Sequencing Mergers & Acquisitions in the Past Five Years
Table 79. Targeted DNA/RNA Sequencing New Entrants and Expansion Plans
Table 80. Global Targeted DNA/RNA Sequencing Revenue (USD Million) by Type (2017-2022)
Table 81. Global Targeted DNA/RNA Sequencing Revenue Share by Type (2017-2022)
Table 82. Global Targeted DNA/RNA Sequencing Revenue Forecast by Type (2023-2028)
Table 83. Global Targeted DNA/RNA Sequencing Revenue by Application (2017-2022)
Table 84. Global Targeted DNA/RNA Sequencing Revenue Forecast by Application (2023-2028)
Table 85. North America Targeted DNA/RNA Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 86. North America Targeted DNA/RNA Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 87. North America Targeted DNA/RNA Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 88. North America Targeted DNA/RNA Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 89. North America Targeted DNA/RNA Sequencing Revenue by Country (2017-2022) & (USD Million)
Table 90. North America Targeted DNA/RNA Sequencing Revenue by Country (2023-2028) & (USD Million)
Table 91. Europe Targeted DNA/RNA Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 92. Europe Targeted DNA/RNA Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 93. Europe Targeted DNA/RNA Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 94. Europe Targeted DNA/RNA Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 95. Europe Targeted DNA/RNA Sequencing Revenue by Country (2017-2022) & (USD Million)
Table 96. Europe Targeted DNA/RNA Sequencing Revenue by Country (2023-2028) & (USD Million)
Table 97. Asia-Pacific Targeted DNA/RNA Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 98. Asia-Pacific Targeted DNA/RNA Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 99. Asia-Pacific Targeted DNA/RNA Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 100. Asia-Pacific Targeted DNA/RNA Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 101. Asia-Pacific Targeted DNA/RNA Sequencing Revenue by Region (2017-2022) & (USD Million)
Table 102. Asia-Pacific Targeted DNA/RNA Sequencing Revenue by Region (2023-2028) & (USD Million)
Table 103. South America Targeted DNA/RNA Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 104. South America Targeted DNA/RNA Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 105. South America Targeted DNA/RNA Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 106. South America Targeted DNA/RNA Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 107. South America Targeted DNA/RNA Sequencing Revenue by Country (2017-2022) & (USD Million)
Table 108. South America Targeted DNA/RNA Sequencing Revenue by Country (2023-2028) & (USD Million)
Table 109. Middle East & Africa Targeted DNA/RNA Sequencing Revenue by Type (2017-2022) & (USD Million)
Table 110. Middle East & Africa Targeted DNA/RNA Sequencing Revenue by Type (2023-2028) & (USD Million)
Table 111. Middle East & Africa Targeted DNA/RNA Sequencing Revenue by Application (2017-2022) & (USD Million)
Table 112. Middle East & Africa Targeted DNA/RNA Sequencing Revenue by Application (2023-2028) & (USD Million)
Table 113. Middle East & Africa Targeted DNA/RNA Sequencing Revenue by Country (2017-2022) & (USD Million)
Table 114. Middle East & Africa Targeted DNA/RNA Sequencing Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Targeted DNA/RNA Sequencing Picture
Figure 2. Global Targeted DNA/RNA Sequencing Revenue Market Share by Type in 2021
Figure 3. DNA-based Targeted Sequencing
Figure 4. RNA-based Targeted Sequencing
Figure 5. Targeted DNA/RNA Sequencing Revenue Market Share by Application in 2021
Figure 6. Human Biomedical Research Picture
Figure 7. Plant & Animal Sciences Picture
Figure 8. Drug Discovery Picture
Figure 9. Others Picture
Figure 10. Global Targeted DNA/RNA Sequencing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Targeted DNA/RNA Sequencing Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Targeted DNA/RNA Sequencing Revenue Market Share by Region (2017-2028)
Figure 13. Global Targeted DNA/RNA Sequencing Revenue Market Share by Region in 2021
Figure 14. North America Targeted DNA/RNA Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Targeted DNA/RNA Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Targeted DNA/RNA Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Targeted DNA/RNA Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Targeted DNA/RNA Sequencing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Targeted DNA/RNA Sequencing Market Drivers
Figure 20. Targeted DNA/RNA Sequencing Market Restraints
Figure 21. Targeted DNA/RNA Sequencing Market Trends
Figure 22. Illumina, Inc. Recent Developments and Future Plans
Figure 23. F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
Figure 24. Agilent Technologies Recent Developments and Future Plans
Figure 25. GATC Biotech Ag Recent Developments and Future Plans
Figure 26. Oxford Nanopore Technologies Recent Developments and Future Plans
Figure 27. Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
Figure 28. DNASTAR Inc. Recent Developments and Future Plans
Figure 29. QIAGEN Recent Developments and Future Plans
Figure 30. BGI Recent Developments and Future Plans
Figure 31. Perkin Elmer, Inc. Recent Developments and Future Plans
Figure 32. Pacific Biosciences of California, Inc. Recent Developments and Future Plans
Figure 33. Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
Figure 34. Integrated DNA Technologies, Inc. Recent Developments and Future Plans
Figure 35. RainDance Technologies, Inc. Recent Developments and Future Plans
Figure 36. PierianDx Recent Developments and Future Plans
Figure 37. Genomatix GmbH Recent Developments and Future Plans
Figure 38. Macrogen, Inc. Recent Developments and Future Plans
Figure 39. Global Targeted DNA/RNA Sequencing Revenue Share by Players in 2021
Figure 40. Targeted DNA/RNA Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 41. Global Top 3 Players Targeted DNA/RNA Sequencing Revenue Market Share in 2021
Figure 42. Global Top 10 Players Targeted DNA/RNA Sequencing Revenue Market Share in 2021
Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 44. Global Targeted DNA/RNA Sequencing Revenue Share by Type in 2021
Figure 45. Global Targeted DNA/RNA Sequencing Market Share Forecast by Type (2023-2028)
Figure 46. Global Targeted DNA/RNA Sequencing Revenue Share by Application in 2021
Figure 47. Global Targeted DNA/RNA Sequencing Market Share Forecast by Application (2023-2028)
Figure 48. North America Targeted DNA/RNA Sequencing Sales Market Share by Type (2017-2028)
Figure 49. North America Targeted DNA/RNA Sequencing Sales Market Share by Application (2017-2028)
Figure 50. North America Targeted DNA/RNA Sequencing Revenue Market Share by Country (2017-2028)
Figure 51. United States Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Canada Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Mexico Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Europe Targeted DNA/RNA Sequencing Sales Market Share by Type (2017-2028)
Figure 55. Europe Targeted DNA/RNA Sequencing Sales Market Share by Application (2017-2028)
Figure 56. Europe Targeted DNA/RNA Sequencing Revenue Market Share by Country (2017-2028)
Figure 57. Germany Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. France Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. United Kingdom Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Russia Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Italy Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Asia-Pacific Targeted DNA/RNA Sequencing Sales Market Share by Type (2017-2028)
Figure 63. Asia-Pacific Targeted DNA/RNA Sequencing Sales Market Share by Application (2017-2028)
Figure 64. Asia-Pacific Targeted DNA/RNA Sequencing Revenue Market Share by Region (2017-2028)
Figure 65. China Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Japan Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South Korea Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. India Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Southeast Asia Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Australia Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South America Targeted DNA/RNA Sequencing Sales Market Share by Type (2017-2028)
Figure 72. South America Targeted DNA/RNA Sequencing Sales Market Share by Application (2017-2028)
Figure 73. South America Targeted DNA/RNA Sequencing Revenue Market Share by Country (2017-2028)
Figure 74. Brazil Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Argentina Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Middle East and Africa Targeted DNA/RNA Sequencing Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Targeted DNA/RNA Sequencing Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Targeted DNA/RNA Sequencing Revenue Market Share by Country (2017-2028)
Figure 79. Turkey Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. UAE Targeted DNA/RNA Sequencing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Methodology
Figure 83. Research Process and Data Source
Publisher: GlobalInfoResearch
Related Reports
- Global Pen Needles Market Analysis and Forecast, 2022-2028
- Global Remote Patient Monitoring Market Analysis and Forecast, 2022-2028
- Global Medical Linear Accelerator Market Analysis and Forecast, 2022-2028
- Global Exoskeleton Market Analysis and Forecast, 2022-2028
- Global Cleanroom Consumables Market Analysis and Forecast, 2022-2028
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support